Optum

Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team

Retrieved on: 
Tuesday, September 5, 2023

WARSAW, Ind., Sept. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team. Wilfred van Zuilen has been promoted to Group President, EMEA; Mark Bezjak was promoted to President of the Americas; and Chief Science, Technology and Innovation Officer Nitin Goyal, M.D. has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos.

Key Points: 
  • Appointed to Executive Leadership Team
    WARSAW, Ind., Sept. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team.
  • has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos.
  • "The expansion of Zimmer Biomet's Executive Leadership Team coincides with our renewed focus on commercial execution and innovation to drive the Company forward," said Mr. Tornos.
  • Wilfred Van Zuilen Promotion to Group President, EMEA
    Mr. van Zuilen joined Zimmer Biomet in June 2021 as President, EMEA.

FSHD Society launches international Walk & Roll to fight FSH muscular dystrophy

Retrieved on: 
Tuesday, September 5, 2023

RANDOLPH, Mass., Sept. 5, 2023 /PRNewswire-PRWeb/ -- The FSHD Society announced the launch today of its sixth annual Walk & Roll to Cure FSHD. The Walk & Roll is the largest - and only - international campaign focused solely on raising funds and awareness for facioscapulohumeral muscular dystrophy (FSHD), a debilitating form of muscular dystrophy that affects nearly one million men, women, and children around the world.

Key Points: 
  • RANDOLPH, Mass., Sept. 5, 2023 /PRNewswire-PRWeb/ -- The FSHD Society announced the launch today of its sixth annual Walk & Roll to Cure FSHD.
  • The Walk & Roll is the largest - and only - international campaign focused solely on raising funds and awareness for facioscapulohumeral muscular dystrophy (FSHD), a debilitating form of muscular dystrophy that affects nearly one million men, women, and children around the world.
  • Kicking off the months-long series of events is the Walk & Roll in British Columbia, one of the newest chapters of the FSHD Society.
  • Everyone is invited to tune in to the FSHD Society Walk & Roll Facebook Live Celebration on September 23rd.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, AMED, RETA, SURF

Retrieved on: 
Tuesday, August 29, 2023

If you are a Decibel shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Decibel shareholder, click here to learn more about your rights and options .
  • If you are an Amedisys shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

NetSPI Moves to New Minneapolis Headquarters to Accommodate Growth

Retrieved on: 
Tuesday, August 29, 2023

MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- NetSPI, the global leader in offensive security, today announced its new headquarters location in the Steelman Exchange building in Minneapolis, Minnesota. The decision to move was prompted by the increasing employee headcount and the need for a more collaborative workplace as the company continues to experience rapid adoption. In 2023 to date, NetSPI has hired 150+ employees, completed 2,733 offensive security assessments, and welcomed 238 new customers.

Key Points: 
  • MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- NetSPI , the global leader in offensive security, today announced its new headquarters location in the Steelman Exchange building in Minneapolis, Minnesota.
  • "The Steelman Exchange is the perfect fit for our team as we enter a momentous and pivotal year for NetSPI," shared Aaron Shilts, CEO at NetSPI.
  • "This investment in our workplace will nurture our continued growth, promote collaboration and innovation in offensive security, and ensure we maintain the unique culture that makes NetSPI so special."
  • The move will take place in January 2024 and NetSPI will remain at its current headquarters at 800 N Washington Ave #670 in Minneapolis until then.

Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position

Retrieved on: 
Wednesday, August 23, 2023

SAN ANTONIO, Aug. 23, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the landscape for real-world evidence (RWE) information technology (IT) solutions for the healthcare industry and, based on its research results, recognizes Optum with the 2023 North American Company of the Year Award. The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD). The division of Optum focused on RWE IT solutions specializes in real-world data, health economics and outcomes research (HEOR), epidemiology, and commercial analytics. The company has worked with RWE for over 25 years and offers a long-term perspective to maintain sustainability, thus providing information to regulators, providers, payers, and patients. The company aims to make healthcare simpler and more effective by transforming evidence into action.

Key Points: 
  • The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD).
  • The division of Optum focused on RWE IT solutions specializes in real-world data, health economics and outcomes research (HEOR), epidemiology, and commercial analytics.
  • Ojaswi Rana, Best Practices Research Analyst, Frost & Sullivan, added, "Optum's research-ready RWD fuels RWE, distinguishing it from other market participants.
  • Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position

Retrieved on: 
Wednesday, August 23, 2023

SAN ANTONIO, Aug. 23, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the landscape for real-world evidence (RWE) information technology (IT) solutions for the healthcare industry and, based on its research results, recognizes Optum with the 2023 North American Company of the Year Award. The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD). The division of Optum focused on RWE IT solutions specializes in real-world data, health economics and outcomes research (HEOR), epidemiology, and commercial analytics. The company has worked with RWE for over 25 years and offers a long-term perspective to maintain sustainability, thus providing information to regulators, providers, payers, and patients. The company aims to make healthcare simpler and more effective by transforming evidence into action.

Key Points: 
  • The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD).
  • The division of Optum focused on RWE IT solutions specializes in real-world data, health economics and outcomes research (HEOR), epidemiology, and commercial analytics.
  • Ojaswi Rana, Best Practices Research Analyst, Frost & Sullivan, added, "Optum's research-ready RWD fuels RWE, distinguishing it from other market participants.
  • Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

DataLink Hires New Chief Sales Officer

Retrieved on: 
Tuesday, August 15, 2023

DataLink , a leading provider of healthcare solutions empowering better outcomes, today announced Karoom Brown has joined the company as chief sales officer.

Key Points: 
  • DataLink , a leading provider of healthcare solutions empowering better outcomes, today announced Karoom Brown has joined the company as chief sales officer.
  • DataLink has been expanding its sales team to support tremendous growth among health plan customers focused on quality performance and risk adjustment accuracy.
  • “As DataLink continues to evolve in the marketplace, we knew we needed a growth-minded sales leader with a depth of entrepreneurial and corporate experience,” said Sandip Patel, chief growth officer.
  • "I’m excited to join the leadership team at DataLink, a company that shares my passion and dedication to advancing healthcare,” said Brown.

Moore Kuehn Encourages TRTN, CFMS, AMED, and NEX Investors to Contact Law Firm

Retrieved on: 
Wednesday, August 9, 2023

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
  • Under the proposed transaction, Triton International shareholders will receive $68.50 in cash and $16.50 in BIPC class A exchangeable shares per share.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

Mantra Health Expands Suite of Mental Health Services in Partnership with Charlie Health

Retrieved on: 
Wednesday, August 9, 2023

Mantra Health, the clinically-informed digital mental health provider for higher education, today announced an innovative new partnership with Charlie Health, the nation’s leading provider of virtual high-acuity mental healthcare for teens and young adults.

Key Points: 
  • Mantra Health, the clinically-informed digital mental health provider for higher education, today announced an innovative new partnership with Charlie Health, the nation’s leading provider of virtual high-acuity mental healthcare for teens and young adults.
  • Mantra Health will add Charlie Health’s industry-leading virtual intensive outpatient program (IOP) to its suite of mental health services, further expanding the levels of care available to students.
  • “Our partnership with Charlie Health expands Mantra Health’s care continuum to solve this vexing problem for our patients and university partners alike.
  • "Charlie Health's collaboration with Mantra comes at a time when the mental health of young people is of the utmost concern," said Carter Barnhart, co-founder and CEO of Charlie Health.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)

Retrieved on: 
Tuesday, August 8, 2023

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, EchoStar will be acquired by DISH Network Corporation (“DISH”) (Nasdaq - DISH).
  • Following completion of the merger, existing DISH shareholders will own approximately 69% and existing EchoStar shareholders will own approximately 31% of the common stock of the combined company.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.